Brenkman Hylke J F, Roelen Stéphanie V S, Steenhagen Elles, Ruurda Jelle P, van Hillegersberg Richard
Cancer Center, Department of Surgery, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands.
Chin J Cancer Res. 2017 Aug;29(4):333-340. doi: 10.21147/j.issn.1000-9604.2017.04.06.
Patients undergoing total gastrectomy for cancer are at risk of malnourishment. The aim of this self-controlled study was to examine the effect of jejunostomy tube feeding (JTF) and other factors on postoperative weight and the incidence of jejunostomy-related complications in patients undergoing total gastrectomy for cancer.
All consecutive patients who underwent total gastrectomy for gastric cancer with jejunostomy placement were included from a prospective single-center database (2003-2014). Jejunostomy-related complications and postoperative weight changes were evaluated up to 12 months after surgery. Multivariable linear regression analysis was performed to identify factors associated with weight loss 12 months after gastrectomy.
Of 113 patients operated in the study period, 65 received JTF after total gastrectomy for a median duration of 18 d [interquartile range (IQR), 10-55 d]. Jejunostomy-related complications occurred in 11 (17%) patients, including skin leakage (n=3) and peritoneal leakage (n=2), luxation (n=3), occlusion (n=2), infection (n=1) and torsion (n=1). In 2 (3%) patients, a reoperation was needed due to jejunostomy-related complications. The mean preoperative weight of patients was 71.8 kg (100%), and remained stable during JTF (73.9 kg, 103%, P=0.331). After JTF was stopped, the mean weight of patients decreased to 64.9 kg (90%) at 12 months after surgery (P<0.001). A high preoperative body mass index (BMI) (≥25 kg/m) was associated with high postoperative weight loss compared to patients with a low BMI (<25 kg/m) (16.3% . 8.6%, P=0.016).
JTF can prevent weight loss in the early postoperative phase. However, this is at the prize of possible complications. As weight loss in the long term is not prevented, routine JTF should be re-evaluated and balanced against the selected use in preoperatively malnourished patients. Special attention should be paid to patients with a high preoperative BMI, who are at risk of more postoperative weight loss.
接受胃癌全胃切除术的患者存在营养不良风险。这项自身对照研究的目的是探讨空肠造口管饲(JTF)及其他因素对接受胃癌全胃切除术患者术后体重及空肠造口相关并发症发生率的影响。
从一个前瞻性单中心数据库(2003 - 2014年)纳入所有连续接受胃癌全胃切除术并放置空肠造口管的患者。对术后长达12个月的空肠造口相关并发症及术后体重变化进行评估。进行多变量线性回归分析以确定与胃切除术后12个月体重减轻相关的因素。
在研究期间接受手术的113例患者中,65例在全胃切除术后接受了JTF,中位持续时间为18天[四分位间距(IQR),10 - 55天]。11例(17%)患者发生了空肠造口相关并发症,包括皮肤渗漏(n = 3)、腹腔渗漏(n = 2)、脱管(n = 3)、堵塞(n = 2)、感染(n = 1)和扭转(n = 1)。2例(3%)患者因空肠造口相关并发症需要再次手术。患者术前平均体重为71.8 kg(100%),在JTF期间保持稳定(73.9 kg,103%,P = 0.331)。停止JTF后,患者术后12个月时平均体重降至64.9 kg(90%)(P < 0.001)。与低体重指数(BMI < 25 kg/m²)的患者相比,术前高体重指数(BMI≥25 kg/m²)与术后高体重减轻相关(16.3%对8.6%,P = 0.016)。
JTF可预防术后早期体重减轻。然而,这是以可能发生并发症为代价的。由于不能预防长期体重减轻,应重新评估常规JTF,并权衡其在术前营养不良患者中的选择性使用。应特别关注术前BMI高的患者,他们术后体重减轻的风险更高。